Glen Eagle Advisors’s Doximity DOCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-100
Closed -$2.33K 1092
2026
Q1
$2.33K Hold
100
﹤0.01% 835
2025
Q4
$4.43K Hold
100
﹤0.01% 789
2025
Q3
$7.32K Hold
100
﹤0.01% 738
2025
Q2
$6.13K Hold
100
﹤0.01% 708
2025
Q1
$5.8K Sell
100
-107
-52% -$6.76K ﹤0.01% 714
2024
Q4
$11.1K Hold
207
﹤0.01% 634
2024
Q3
$9.02K Sell
207
-63
-23% -$2.1K ﹤0.01% 675
2024
Q2
$7.55K Hold
270
﹤0.01% 695
2024
Q1
$7.27K Hold
270
﹤0.01% 718
2023
Q4
$7.57K Hold
270
﹤0.01% 676
2023
Q3
$5.73K Hold
270
﹤0.01% 708
2023
Q2
$9.19K Hold
270
﹤0.01% 648
2023
Q1
$8.74K Hold
270
﹤0.01% 638
2022
Q4
$9.06K Hold
270
﹤0.01% 632
2022
Q3
$8.16K Buy
270
+11
+4% +$403 ﹤0.01% 628
2022
Q2
$9.02K Buy
259
+21
+9% +$827 ﹤0.01% 637
2022
Q1
$12.4K Buy
238
+13
+6% +$654 ﹤0.01% 589
2021
Q4
$11.3K Hold
225
﹤0.01% 598
2021
Q3
$18.2K Buy
225
+135
+150% +$9.87K 0.01% 573
2021
Q2
$5.24K Buy
+90
New +$5.05K ﹤0.01% 808

Other funds holding DOCS

Glen Eagle Advisors's DOCS Position: Q2 2026 in Review

Glen Eagle Advisors sold out of Doximity (DOCS) in Q2 2026, closing a stake of 100 shares — an estimated $2.33K sold.

Glen Eagle Advisors first reported a position in DOCS in Q2 2021 and held it in 20 quarters. The position peaked at $18.2K in Q3 2021. 358 funds tracked by Wall St. Rank hold DOCS as of Q2 2026.

  • Glen Eagle Advisors reported no remaining Doximity position as of Q2 2026 after selling out during the quarter.
  • Glen Eagle Advisors sold 100 Doximity shares in Q2 2026, an estimated $2.33K.
  • Glen Eagle Advisors first reported a position in Doximity in Q2 2021 and held it in 20 quarters.
  • Glen Eagle Advisors's Doximity position peaked at $18.2K in Q3 2021.
  • 358 funds tracked by Wall St. Rank held Doximity as of Q2 2026.

Based on Glen Eagle Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.